Prana Biotechnology Limited (ADR) (PRAN): Phase II Results Approaching for …

Prana Biotechnology Limited (ADR) (PRAN): Phase II Results Approaching For …
Identifying patients early however helps them plan for their future, manage their co-morbidities and exclude the treatable causes of dementia i.e. thyroid disease, depression. The FDA has also given guidance to industry that it may accept biomarkers … Read more on Seeking Alpha

Life After Hepatitis C: It's No Longer a 'Death Sentence'
Martinez and other patients in the study had not responded to interferon, the injection-based current standard of treatment. Interferon can cause severe unwanted side effects, including depression, nausea, and lethargy. Other new drug candidates … Read more on Healthline